EC Number | Application | Comment | Organism |
---|---|---|---|
1.6.5.2 | drug development | new coumarin-based competitive inhibitors of NQO1. NQO1 inhibition as an anticancer drug design target and superoxide generation as the dicoumarol-mediated mechanism of cytotoxicity | Homo sapiens |
EC Number | Cloned (Comment) | Organism |
---|---|---|
1.6.5.2 | - |
Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.6.5.2 | 3,3'-(9H-fluoren-3-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-(biphenyl-4-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-(furan-2-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-(naphthalen-2-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-(phenylmethanediyl)bis(4,7-dihydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-(phenylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-(pyridin-2-ylmethanediyl)bis(4,7-dihydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-(quinolin-3-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-(thiophen-2-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-([4-[(E)-2-phenylethenyl]phenyl]methanediyl)bis(4-hydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-methanediylbis(4,7-dihydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-[(4-chlorophenyl)methanediyl]bis(4-hydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-[(4-hydroxy-3-methoxyphenyl)methanediyl]bis(4-hydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-[(4-hydroxyphenyl)methanediyl]bis(4-hydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-[(4-methoxyphenyl)methanediyl]bis(4-hydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-[[3,5-bis(benzyloxy)phenyl]methanediyl]bis(4-hydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-[[4-(1-methylethyl)phenyl]methanediyl]bis(4-hydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3,3'-[[4-(dimethylamino)phenyl]methanediyl]bis(4-hydroxy-2H-chromen-2-one) | - |
Homo sapiens | |
1.6.5.2 | 3-[[3-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]phenyl](4-hydroxy-2-oxo-4a,8a-dihydro-2H-chromen-3-yl)methyl]-4-hydroxy-2H-chromen-2-one | - |
Homo sapiens | |
1.6.5.2 | 3-[[4-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]phenyl](4,7-dihydroxy-2-oxo-4a,8a-dihydro-2H-chromen-3-yl)methyl]-4,7-dihydroxy-2H-chromen-2-one | - |
Homo sapiens | |
1.6.5.2 | 3-[[4-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]phenyl](4-hydroxy-2-oxo-4a,8a-dihydro-2H-chromen-3-yl)methyl]-4-hydroxy-2H-chromen-2-one | - |
Homo sapiens | |
1.6.5.2 | 4-amino-2H-chromen-2-one | - |
Homo sapiens | |
1.6.5.2 | 4-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]benzoic acid | - |
Homo sapiens | |
1.6.5.2 | 7-(4-hydroxy-2-oxo-2H-chromen-3-yl)-6a,7-dihydro-4aH,6H,8H-pyrano[3,2-c:5,6-c']dichromene-6,8-dione | - |
Homo sapiens | |
1.6.5.2 | 7-(4-hydroxy-2-oxo-2H-chromen-3-yl)-6H,7H-chromeno[4,3-b]chromen-6-one | - |
Homo sapiens | |
1.6.5.2 | dicoumarol | - |
Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.6.5.2 | Homo sapiens | P15559 | - |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
1.6.5.2 | - |
Homo sapiens |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.6.5.2 | MiaPaCa-2 cell | - |
Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.6.5.2 | menadione + NADH | - |
Homo sapiens | reduced menadione + NAD+ | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.6.5.2 | NAD(P)H quinone oxidoreductase-1 | - |
Homo sapiens |
1.6.5.2 | NQO1 | - |
Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.6.5.2 | FAD | - |
Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
1.6.5.2 | 0.000005 | - |
- |
Homo sapiens | 3,3'-methanediylbis(4,7-dihydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.000005 | - |
without bovine serum albumin | Homo sapiens | dicoumarol | |
1.6.5.2 | 0.000014 | - |
- |
Homo sapiens | 3,3'-(naphthalen-2-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.0001 | - |
- |
Homo sapiens | 3,3'-[[4-(dimethylamino)phenyl]methanediyl]bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.00011 | - |
- |
Homo sapiens | 3-[[4-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]phenyl](4-hydroxy-2-oxo-4a,8a-dihydro-2H-chromen-3-yl)methyl]-4-hydroxy-2H-chromen-2-one | |
1.6.5.2 | 0.00015 | - |
- |
Homo sapiens | 3,3'-(9H-fluoren-3-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.0002 | - |
- |
Homo sapiens | 7-(4-hydroxy-2-oxo-2H-chromen-3-yl)-6H,7H-chromeno[4,3-b]chromen-6-one | |
1.6.5.2 | 0.00022 | - |
- |
Homo sapiens | 3,3'-[(4-methoxyphenyl)methanediyl]bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.00025 | - |
- |
Homo sapiens | 3-[[4-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]phenyl](4,7-dihydroxy-2-oxo-4a,8a-dihydro-2H-chromen-3-yl)methyl]-4,7-dihydroxy-2H-chromen-2-one | |
1.6.5.2 | 0.00025 | - |
- |
Homo sapiens | 7-(4-hydroxy-2-oxo-2H-chromen-3-yl)-6a,7-dihydro-4aH,6H,8H-pyrano[3,2-c:5,6-c']dichromene-6,8-dione | |
1.6.5.2 | 0.00035 | - |
- |
Homo sapiens | 3,3'-[[4-(1-methylethyl)phenyl]methanediyl]bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.00035 | - |
- |
Homo sapiens | 3,3'-([4-[(E)-2-phenylethenyl]phenyl]methanediyl)bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.00035 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-methanediylbis(4,7-dihydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.00038 | - |
- |
Homo sapiens | 3,3'-(quinolin-3-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.00045 | - |
in the presence of bovine serum albumin | Homo sapiens | dicoumarol | |
1.6.5.2 | 0.0005 | - |
- |
Homo sapiens | 3-[[3-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]phenyl](4-hydroxy-2-oxo-4a,8a-dihydro-2H-chromen-3-yl)methyl]-4-hydroxy-2H-chromen-2-one | |
1.6.5.2 | 0.00055 | - |
- |
Homo sapiens | 3,3'-(thiophen-2-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.0006 | - |
in the presence of bovine serum albumin | Homo sapiens | 7-(4-hydroxy-2-oxo-2H-chromen-3-yl)-6a,7-dihydro-4aH,6H,8H-pyrano[3,2-c:5,6-c']dichromene-6,8-dione | |
1.6.5.2 | 0.00065 | - |
- |
Homo sapiens | 3,3'-[(4-hydroxy-3-methoxyphenyl)methanediyl]bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.00065 | - |
in the presence of bovine serum albumin | Homo sapiens | 7-(4-hydroxy-2-oxo-2H-chromen-3-yl)-6H,7H-chromeno[4,3-b]chromen-6-one | |
1.6.5.2 | 0.00088 | - |
- |
Homo sapiens | 3,3'-(biphenyl-4-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.00125 | - |
- |
Homo sapiens | 3,3'-[[3,5-bis(benzyloxy)phenyl]methanediyl]bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.0013 | - |
- |
Homo sapiens | 3,3'-(furan-2-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.0017 | - |
- |
Homo sapiens | 4-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]benzoic acid | |
1.6.5.2 | 0.0022 | - |
- |
Homo sapiens | 3,3'-[(4-chlorophenyl)methanediyl]bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.0023 | - |
- |
Homo sapiens | 3,3'-[(4-hydroxyphenyl)methanediyl]bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.0029 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-[[4-(1-methylethyl)phenyl]methanediyl]bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.00325 | - |
- |
Homo sapiens | 4-amino-2H-chromen-2-one | |
1.6.5.2 | 0.0042 | - |
- |
Homo sapiens | 3,3'-(phenylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.005 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-[[4-(dimethylamino)phenyl]methanediyl]bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.0059 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-(furan-2-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.0075 | - |
- |
Homo sapiens | 3,3'-(phenylmethanediyl)bis(4,7-dihydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.008 | - |
- |
Homo sapiens | 3,3'-(pyridin-2-ylmethanediyl)bis(4,7-dihydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.0085 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-(naphthalen-2-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.0087 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-[(4-methoxyphenyl)methanediyl]bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.01 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-(thiophen-2-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.01 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-[(4-hydroxy-3-methoxyphenyl)methanediyl]bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.013 | - |
in the presence of bovine serum albumin | Homo sapiens | 4-amino-2H-chromen-2-one | |
1.6.5.2 | 0.018 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-(quinolin-3-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.02 | - |
in the presence of bovine serum albumin | Homo sapiens | 3-[[4-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]phenyl](4-hydroxy-2-oxo-4a,8a-dihydro-2H-chromen-3-yl)methyl]-4-hydroxy-2H-chromen-2-one | |
1.6.5.2 | 0.021 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-(phenylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.021 | - |
in the presence of bovine serum albumin | Homo sapiens | 4-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]benzoic acid | |
1.6.5.2 | 0.0225 | - |
in the presence of bovine serum albumin | Homo sapiens | 3-[[3-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]phenyl](4-hydroxy-2-oxo-4a,8a-dihydro-2H-chromen-3-yl)methyl]-4-hydroxy-2H-chromen-2-one | |
1.6.5.2 | 0.024 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-(pyridin-2-ylmethanediyl)bis(4,7-dihydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.028 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-[(4-chlorophenyl)methanediyl]bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.035 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-[(4-hydroxyphenyl)methanediyl]bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.041 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-(9H-fluoren-3-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.0445 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-(biphenyl-4-ylmethanediyl)bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.05 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-[[3,5-bis(benzyloxy)phenyl]methanediyl]bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.055 | - |
in the presence of bovine serum albumin | Homo sapiens | 3-[[4-[bis(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]phenyl](4,7-dihydroxy-2-oxo-4a,8a-dihydro-2H-chromen-3-yl)methyl]-4,7-dihydroxy-2H-chromen-2-one | |
1.6.5.2 | 0.06 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-([4-[(E)-2-phenylethenyl]phenyl]methanediyl)bis(4-hydroxy-2H-chromen-2-one) | |
1.6.5.2 | 0.082 | - |
in the presence of bovine serum albumin | Homo sapiens | 3,3'-(phenylmethanediyl)bis(4,7-dihydroxy-2H-chromen-2-one) |